AIMC Topic: Non-alcoholic Fatty Liver Disease

Clear Filters Showing 71 to 80 of 139 articles

Hepatoprotective Activity of Lignin-Derived Polyphenols Dereplicated Using High-Resolution Mass Spectrometry, In Vivo Experiments, and Deep Learning.

International journal of molecular sciences Dec 16, 2022
Chronic liver diseases affect more than 1 billion people worldwide and represent one of the main public health issues. Nonalcoholic fatty liver disease (NAFLD) accounts for the majority of mortal cases, while there is no currently approved therapeuti...
Humans Mass Spectrometry Polyphenols Non-alcoholic Fatty Liver Disease Lignin Molecular Docking Simulation Deep Learning Proteomics
View on PubMed DOI

Artificial intelligence model with deep learning in nonalcoholic fatty liver disease diagnosis: genetic based artificial neural networks.

Nucleosides, nucleotides & nucleic acids Nov 30, 2022
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the world. The NAFLD spectrum includes simple steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Genetic, nutritio...
Artificial Intelligence Deep Learning Liver Neoplasms Carcinoma, Hepatocellular Humans Neural Networks, Computer Polymorphism, Single Nucleotide Insulin Resistance Non-alcoholic Fatty Liver Disease
View on PubMed DOI

Characterization of signature trends across the spectrum of non-alcoholic fatty liver disease using deep learning method.

Life sciences Nov 24, 2022
AIMS: The timely diagnosis of different stages in NAFLD is crucial for disease treatment and reversal. We used hepatocellular ballooning to determine different NAFLD stages.
Carcinoma, Hepatocellular Liver Non-alcoholic Fatty Liver Disease Humans Deep Learning Liver Neoplasms
View on PubMed DOI

Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies.

Scientific reports Nov 10, 2022
Non-alcoholic fatty liver disease (NAFLD) affects about 24% of the world's population. Progression of early stages of NAFLD can lead to the more advanced form non-alcoholic steatohepatitis (NASH), and ultimately to cirrhosis or liver cancer. The curr...
Biopsy Non-alcoholic Fatty Liver Disease Fibrosis Inflammation Liver Cirrhosis Liver Severity of Illness Index Deep Learning Humans Reproducibility of Results
View on PubMed DOI

Danshao Shugan Granule therapy for non-alcoholic fatty liver disease.

Lipids in health and disease Aug 23, 2022
BACKGROUND: Danshao Shugan Granules (DSSG), a traditional Chinese medicine (TCM), is given to protect the liver. The objective is to evaluate the mechanisms of the effects of DSSG on non-alcoholic fatty liver disease (NAFLD).
Rats Malondialdehyde Superoxide Dismutase Liver NF-kappa B Medicine, Chinese Traditional Rats, Sprague-Dawley Humans Animals Mice Aspartate Aminotransferases Triglycerides Rosiglitazone Silybin Cholesterol Non-alcoholic Fatty Liver Disease Alanine Transaminase
View on PubMed DOI

Comparative Study of Raw Ultrasound Data Representations in Deep Learning to Classify Hepatic Steatosis.

Ultrasound in medicine & biology Jul 30, 2022
Adiposity accumulation in the liver is an early-stage indicator of non-alcoholic fatty liver disease. Analysis of ultrasound (US) backscatter echoes from liver parenchyma with deep learning (DL) may offer an affordable alternative for hepatic steatos...
Deep Learning Ultrasonography ROC Curve Liver Humans Artificial Intelligence Non-alcoholic Fatty Liver Disease
View on PubMed DOI

Very low-volume interval training improves nonalcoholic fatty liver disease fibrosis score and cardiometabolic health in adults with obesity and metabolic syndrome.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society Apr 24, 2022
Non-alcoholic fatty liver disease (NAFLD) and cardiometabolic disorders are highly prevalent in obese individuals. Physical exercise is an important element in obesity and metabolic syndrome (MetS) treatment. However, the vast majority of individuals...
Non-alcoholic Fatty Liver Disease Fibrosis Weight Loss Metabolic Syndrome Obesity Humans Adult Cardiovascular Diseases
View on PubMed DOI

The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.

Molecules (Basel, Switzerland) Jan 18, 2022
(AG) is an ancient medicinal plant that is mainly distributed and used in southwest China. It exerts therapeutic effects, such as antioxidant, anti-diabetic, and anti-inflammatory activities, reductions in blood pressure and cholesterol and hepatopr...
Lipogenesis Fatty Liver, Alcoholic Mice, Obese Obesity Diet, High-Fat Anti-Obesity Agents Tea Rats Rats, Sprague-Dawley Mice, Inbred C57BL Non-alcoholic Fatty Liver Disease Adiposity 3T3-L1 Cells Phytotherapy Flavonoids Mice, Inbred ICR Lipid Metabolism Animals Antioxidants Plant Extracts Male Mice
View on PubMed DOI

Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.

Radiology Nov 16, 2021
Background Standardized manual region of interest (ROI) sampling strategies for hepatic MRI steatosis and iron quantification are time consuming, with variable results. Purpose To evaluate the performance of automatic MRI whole-liver segmentation (WL...
Iron Overload Male Middle Aged Deep Learning Biopsy Non-alcoholic Fatty Liver Disease Magnetic Resonance Imaging Chronic Disease Prospective Studies Female Cross-Sectional Studies Humans
View on PubMed DOI

Development of machine learning model to detect fibrotic non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver Aug 13, 2021
Non-alcoholic Fatty Liver Disease Fibrosis Humans Machine Learning Female Male Middle Aged Adult Cross-Sectional Studies
View on PubMed DOI
Popular Topics
Recent Journals